Cite
MLA Citation
Tianyao Lei et al.. “Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis.” Pharmacological research, vol. 188, 2023, p. . http://access.bl.uk/ark:/81055/vdc_100177575112.0x00001e